CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 233 enrolled
Drug / intervention
Lidocaine jelly +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03595449
NCT03595449Phase 4Completed

Patient Satisfaction in Mohs Micrographic Surgery With Supplemental Lidocaine Jelly

Mayo Clinic·interventional·Posted Jul 23, 2018·Updated Jul 13, 2021

In Brief

A Phase 4 clinical trial evaluating Lidocaine jelly and Surgilube for Pain and Satisfaction, Consumer. Completed, enrolled 233 participants across 1 site.

Detailed Summary

Does the use of lidocaine jelly during Mohs surgery on the nose decrease the total amount of lidocaine used during surgery. Does patient satisfaction improve when lidocaine jelly is used during Mohs surgery of the nose?

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedJul 23, 2018
Enrollment StartAug 13, 2018
Primary CompletionAug 31, 2020
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 7.9 years ago

Interventions

Lidocaine jellydrug

lidocaine 2% jelly applied during Mohs surgery

Surgilubedrug

surgilube (placebo) applied during Mohs surgery